Freezers Segment has the Largest Share of Type in the Asia Pacific Cryopreservation Equipment Market during 2021-2028
According to a new market research study on “Asia Pacific Cryopreservation Equipment Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Cryogen Type, Application and End-user,” is expected to reach US$ 1,663.5 million by 2028 from US$ 821.1 million in 2021. The market is estimated to grow at a CAGR of 10.6% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific cryopreservation equipment market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the growing acceptance for regenerative medicine and increasing needs of biobanking practices are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the stringent regulatory requirements for equipment, reagents, cryogens, disposables, and consumables.
Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in healthcare industry. Moreover, medical device companies are starting to forecast large sales declines in their Chinese markets because people are staying at home. Many big medical device companies such as Philips, GE Healthcare, and Hill-Rom amongst others have predicated the decline in sales in China. On the other hand, restricted access to family planning services, economic uncertainty and recession, and reduced work-life balance led to increasing number of egg and embryo freezing during the pandemic. Asia-Pacific region and beyond have taken unprecedented steps to curb the spread of the virus and provide care for the many infected individuals. Crucially, the impact of the pandemic on fertility is associated with huge uncertainty. Thus, the rising use of cryopreservation equipment during the pandemic is likely to pose a positive impact on the market.
The market for cryopreservation equipment market is segmented into type, cryogen type, application, and End-user. Based on type, the cryopreservation equipment market is segmented into freezers, sample preparation systems, and accessories. In 2020, the freezers segment held the largest share of the market, by type. Moreover, the same segment is estimated to grow at significant CAGR due to versatile nature of freezers to be used in various settings, easy to use, technological advances, increasing product launches, and high adoption of freezers in stem cell banks during the forecast period.
Thermo Fisher Scientific Inc. Gold Sim Cellular Science Llc, Brooks Automation, Inc. Avantor, Inc. Hamilton Company, PHC Holdings Corporation, General Electric Company, Cryoport Systems, LLC. Antech Group Inc. BioLife Solutions, and ZhongkeMeiling Cryogenics Company Limited are among the leading companies in the Asia Pacific cryopreservation equipment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2021, with an initial shipment to a leading cell treatment business, BioLife Solutions, Inc. released a new line of high capacity-controlled rate freezers (HCRF).
According to a new market research study on “Asia Pacific Cryopreservation Equipment Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Cryogen Type, Application and End-user,” is expected to reach US$ 1,663.5 million by 2028 from US$ 821.1 million in 2021. The market is estimated to grow at a CAGR of 10.6% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific cryopreservation equipment market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the growing acceptance for regenerative medicine and increasing needs of biobanking practices are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the stringent regulatory requirements for equipment, reagents, cryogens, disposables, and consumables.
Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in healthcare industry. Moreover, medical device companies are starting to forecast large sales declines in their Chinese markets because people are staying at home. Many big medical device companies such as Philips, GE Healthcare, and Hill-Rom amongst others have predicated the decline in sales in China. On the other hand, restricted access to family planning services, economic uncertainty and recession, and reduced work-life balance led to increasing number of egg and embryo freezing during the pandemic. Asia-Pacific region and beyond have taken unprecedented steps to curb the spread of the virus and provide care for the many infected individuals. Crucially, the impact of the pandemic on fertility is associated with huge uncertainty. Thus, the rising use of cryopreservation equipment during the pandemic is likely to pose a positive impact on the market.
The market for cryopreservation equipment market is segmented into type, cryogen type, application, and End-user. Based on type, the cryopreservation equipment market is segmented into freezers, sample preparation systems, and accessories. In 2020, the freezers segment held the largest share of the market, by type. Moreover, the same segment is estimated to grow at significant CAGR due to versatile nature of freezers to be used in various settings, easy to use, technological advances, increasing product launches, and high adoption of freezers in stem cell banks during the forecast period.
Thermo Fisher Scientific Inc. Gold Sim Cellular Science Llc, Brooks Automation, Inc. Avantor, Inc. Hamilton Company, PHC Holdings Corporation, General Electric Company, Cryoport Systems, LLC. Antech Group Inc. BioLife Solutions, and ZhongkeMeiling Cryogenics Company Limited are among the leading companies in the Asia Pacific cryopreservation equipment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2021, with an initial shipment to a leading cell treatment business, BioLife Solutions, Inc. released a new line of high capacity-controlled rate freezers (HCRF).
The report segments the Asia Pacific Cryopreservation Equipment market as follows:
By Type
- Freezers
- Sample Preparation Systems
- Accessories
- Freezer Boxes
- Freezer Racks
- Cryopreservation Vials
- Others
By Cryogen Type
- Liquid Nitrogen
- Oxygen
- Liquid Helium
- Argon
- Others
By Application
- Cord Blood Stem Cells
- Sperms Semen and Testicular Tissues
- Embryos and Oocytes
- Cell and Gene Therapies
- Others
By End-user
- Stem Cell Banks
- Biotechnology and Pharmaceutical Organizations
- Stem Cell Research Laboratories
- Others
By Country
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-eastern Asia
- Rest of Asia Pacific
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific cryopreservation equipment market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cryopreservation equipment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the cryopreservation equipment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the Asian Pacific Cryopreservation Equipment Market
What is the estimated value of the Asian Pacific Cryopreservation Equipment Market?
What is the growth rate of the Asian Pacific Cryopreservation Equipment Market?
What is the forecasted size of the Asian Pacific Cryopreservation Equipment Market?
Who are the key companies in the Asian Pacific Cryopreservation Equipment Market?
Report Attribute | Details |
---|---|
No. of Pages | 174 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 821.1 Million |
Forecasted Market Value ( USD | $ 1663.5 Million |
Compound Annual Growth Rate | 10.6% |
Regions Covered | Asia Pacific |
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Cryopreservation Equipment Market - Market Landscape
5. Asia Pacific Cryopreservation Equipment Market - Key Market Dynamics
6. Cryopreservation Equipment Market - Asia Pacific Analysis
7. Asia Pacific Cryopreservation Equipment Market Analysis and Forecasts To 2028 - By Type
8. Asia Pacific Cryopreservation Equipment Market Analysis and Forecasts To 2028 - By Cryogen Type
9. Asia Pacific Cryopreservation Equipment Market Analysis and Forecasts To 2028 - By Application
10. Asia Pacific Cryopreservation Equipment Market Analysis and Forecasts to 2028 - By End User
11. Cryopreservation Equipment Market Revenue and Forecasts to 2028 - Geographical Analysis
12. Impact Of COVID-19 Pandemic on Asia Pacific Cryopreservation Equipment Market
13. Industry Landscape
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Thermo Fisher Scientific Inc.
- Gold Sim Cellular Science Llc
- Brooks Automation, Inc
- Avantor, Inc.
- Hamilton Company
- PHC Holdings Corporation
- General Electric Company
- Cryoport Systems, LLC.
- Antech Group Inc.
- BioLife Solutions
- ZhongkeMeiling Cryogenics Company Limited